Cardiovascular risk profile at the onset of psoriatic arthritis: A population-based cohort study

Arthritis Care and Research

Volumn 67, Issue 7, 2015, Pages 1015-1021

  Ernste, F C ^a   Sanchez Menendez M ^b   Wilton, K M ^c   Crowson, C S ^a   Matteson, E L ^a   Maradit Kremers, H ^a  

^a MAYO CLINIC   (United States)

^b Centro Medico de Asturias   (Spain)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; PSORIATIC ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; HEALTH SURVEY; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84932617838     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22536     Document Type: Article

References (42)

1. Tam LS, Tomlinson B, Chu TT, Li M, Leung YY, Kwok LW, et al., Cardiovascular risk profile of patients with psoriatic arthritis compared to controls: the role of inflammation. Rheumatology (Oxford) 2008; 47: 718-23.
2. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M., Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 321-8.
3. Mehta NN, YiDing Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, et al., Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 2011; 124; 775.e1-6.e1.
4. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB., Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41.
5. Horreau C, Pouplard C, Brenaut E, Barnetche T, Misery L, Cribier B, et al., Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 2013; 27: 12-29.
6. Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT., Cardiovascular risk profile of patients with spondyloarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004; 34: 585-92.
7. Gladman DD., Mortality in psoriatic arthritis. Clin Exp Rheumatol 2008; 26 Suppl 51: S62-5.
8. Wong K, Gladman DD, Husted J, Long JA, Farewell VT., Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997; 40: 1868-72.
9. Mok CC, Ko GT, Ho LY, Yu KL, Chan PT, To CH., Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res (Hoboken) 2011; 63: 195-202.
10. Ahlehoff O, Skov L, Gislason G, Lindhardsen J, Kristensen SL, Iversen L, et al., Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study. J Intern Med 2013; 273: 197-204.
11. Maradit-Kremers H, Icen M, Ernste FC, Dierkhising RA, McEvoy MT., Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study. J Eur Acad Dermatol Venereol 2012; 26: 336-43.
12. Davidovici BB, Sattar N, Prinz J, Puig L, Emery P, Barker JN, et al., Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130: 1785-96.
13. Zhu TY, Li EK, Tam LS., Cardiovascular risk in patients with psoriatic arthritis. Int J Rheumatol 2012;2012: 714321.
14. Gabriel SE, Crowson CS., Risk factors for cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 2012; 24: 171-6.
15. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, et al., Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005; 52: 402-11.
16. Kremers HM, Crowson CS, Therneau TM, Roger VL, Gabriel SE., High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum 2008; 58: 2268-74.
17. Favarato MH, Mease P, Goncalves CR, Goncalves SC, Sampaio-Barros PD, Goldenstein-Schainberg C., Hypertension and diabetes significantly enhance the risk of cardiovascular disease in patients with psoriatic arthritis. Clin Exp Rheumatol 2014; 32: 182-7.
18. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB., Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47.
19. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM., General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-53.
20. Melton LJ III,. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71: 266-74.
21. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al., Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73.
22. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM., Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study. J Rheumatol 2009; 36: 361-7.
23. Scarpa R, Cuocolo A, Peluso R, Atteno M, Gisonni P, Iervolino S, et al., Early psoriatic arthritis: the clinical spectrum. J Rheumatol 2008; 35: 137-41.
24. Kane D, Stafford L, Bresnihan B, FitzGerald O., A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003; 42: 1460-8.
25. Alberti KG, Zimmet PZ., Definition, diagnosis and classification of diabetes mellitus and its complications: part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
26. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998; 158: 1855-67.
27. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
28. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al., The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003; 289: 2560-72.
29. Crowson CS, Atkinson EJ, Therneau TM., Assessing calibration of prognostic risk scores. Stat Methods Med Res. E-pub ahead of print.
30. Flegal KM, Carroll MD, Kit BK, Ogden CL., Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-7.
31. Centers for Disease Control and Prevention. Current cigarette smoking among adults: United States, 2005-2012. MMWR Morb Mortal Wkly Rep 2014; 63: 29-34.
32. Naldi L, Mercuri SR., Smoking and psoriasis: from epidemiology to pathomechanisms. J Invest Dermatol 2009; 129: 2741-3.
33. Wolk K, Mallbris L, Larsson P, Rosenblad A, Vingard E, Stahle M. Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Derm Venereol 2009; 89: 492-7.
34. Saydah S, Bullard KM, Cheng Y, Ali MK, Gregg EW, Geiss L, et al., Trends in cardiovascular disease risk factors by obesity level in adults in the United States, NHANES 1999-2010. Obesity (Silver Spring) 2014; 22: 1888-95.
35. Allal-El Asmi M, Mebazaa A, Zidi W, Zayani Y, Feki M, Mokni M, et al., Psoriasis is associated with increased Framingham ten-year risk score for coronary heart disease in Tunisians. Clin Lab 2013; 59: 1247-52.
36. Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA., High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007; 57: 1074-80.
37. Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE., Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol 2012; 110: 420-4.
38. Gossec L, Salejan F, Nataf H, Nguyen M, Gaud-Listrat V, Hudry C, et al., Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 2013; 65: 712-7.
39. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al., EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325-31.
40. Kimball AB, Guerin A, Latremouille-Viau D, Yu AP, Gupta S, Bao Y, et al., Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis. Am J Med 2010; 123: 350-7.
41. St. Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ III, Rocca WA., Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc 2012; 87: 151-60.
42. Papagoras C, Markatseli TE, Saougou I, Alamanos Y, Zikou AK, Voulgari PV, et al., Cardiovascular risk profile in patients with spondyloarthritis. Joint Bone Spine 2014; 81: 57-63.